About

Novo Nordisk A/S is a Danish multinational pharmaceutical and health care company, headquartered in Bagsværd, Denmark. Founded on 21 December 1923, the company has grown to operate with production facilities in nine countries and affiliates or offices in five. As a public company, it reported a substantial revenue of 290.4 billion kr. in 2024. Novo Nordisk is notably controlled by its majority shareholder, Novo Holdings A/S, which is wholly owned by the Novo Nordisk Foundation, holding approximately 28.1% of its shares and a dominant 77.1% of its voting shares. While specific details on its complete product portfolio, current leadership, employee count, and direct competitors are not provided, its global presence and financial performance underscore its significant market position in the pharmaceutical sector.